leisure time -WSS

leisure time

author：entertainment 2025-08-08 08:10:04 - browse：9

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： An outrageous hospital charge: I paid $710 for an hour of babysitting

focus

WSS

AI gets buy

Gene therapy for Afghan refugees’ infant will be fully covered

Top private equity targets in 2023: cardiology, clinical trials, lasers

Marc Tessier

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

CDC: Cases of alpha

knowledge

leisure time

hotspot

How one medical school became remarkably diverse

The Biogen Aduhelm mess could happen again

Heart attack and stroke risk calculators need revising

Medicare Advantage plans can’t deny care with AI, CMS warns

The high cost of giving birth even with insurance

Updated Covid vaccine has 54% effectiveness, new study suggests

Wildfire smoke exposes gaps in outdoor worker protections

Gene therapy for Afghan refugees’ infant will be fully covered

In Memoriam: Notable people who died in 2023

Medicare Advantage plans can’t deny care with AI, CMS warns

focus

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Gene therapy for Afghan refugees’ infant will be fully covered

Biden jokes that Republicans may impeach him because inflation is starting to cool down

The Biogen Aduhelm mess could happen again

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Interest rates are at a 22

explore

focus

focus

Wikipedia